Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS
Source: SeekingAlpha
2025-12-01 08:00:00 ET
...
Read the full article on Seeking Alpha
For further details see:
Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS
Harrow Health Inc.
NASDAQ: HROW
HROW Trading
-5.34% G/L:
$33.945 Last:
371,146 Volume:
$35.24 Open:
HROW Latest News
March 24, 2026 04:57:00 pm
Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030
March 24, 2026 09:38:57 am
A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal?
March 24, 2026 08:15:00 am
Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support Growth
